Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint Infections
Conditions: Bone and Joint Infection; Patient Treated by Daptomycin Intervention: Sponsor: Hospices Civils de Lyon Completed - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 4, 2017 Category: Research Source Type: clinical trials
Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center
Conditions: Bone and Joint Infection; Treated by Daptomycin Intervention: Sponsor: Hospices Civils de Lyon Completed - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 4, 2017 Category: Research Source Type: clinical trials
Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
Condition: Staphylococcus Aureus Bacteremia Interventions: Drug: Ceftobiprole medocaril; Drug: Daptomycin Sponsors: Basilea Pharmaceutica; Department of Health and Human Services Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials
Population Pharmacokinetic Analysis of Daptomycin in Patients With Osteoarticular Infections
Conditions: Bone Infection; Joint Infection Intervention: Sponsor: Hospices Civils de Lyon Active, not recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2017 Category: Research Source Type: clinical trials
